Year archive

Jacobio Pharmaceuticals Group Co., Ltd. — 2021 filings

All 37 regulatory filings released by Jacobio Pharmaceuticals Group Co., Ltd. (1167) in 2021, sourced directly from the official regulator.

37 Filings

2021 Period

2021 filings (37)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT JACOBIO ANNOUNCES THE INVESTIGATIONAL NEW DRUG APPROVAL FOR THE CONBINATION THERAPY OF KRAS G12C INHIBITOR JAB-21822 AND CENTUXIMAB INJECTION IN CHINA Regulatory Filings	2021-12-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2021 Regulatory Filings	2021-12-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2021 Regulatory Filings	2021-11-03	English
VOLUNTARY ANNOUNCEMENT INVESTIGATIONAL NEW DRUG (IND) APPROVAL FOR CD73 mAb JAB-BX102 IN THE UNITED STATES Regulatory Filings	2021-10-15	English
SUPPLEMENTAL ANNOUNCEMENT ADOPTION OF 2021 STOCK INCENTIVE PLAN Share Issue/Capital Change	2021-10-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2021 Regulatory Filings	2021-10-06	English
2021 INTERIM REPORT Interim / Quarterly Report	2021-09-24	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2021 Regulatory Filings	2021-09-03	English
ADOPTION OF 2021 STOCK INCENTIVE PLAN Capital/Financing Update	2021-08-31	English
CONNECTED TRANSACTION PURCHASE OF SERIES A SHARES IN HEBECELL Capital/Financing Update	2021-08-31	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021 Interim / Quarterly Report	2021-08-31	English
DATE OF BOARD MEETING Report Publication Announcement	2021-08-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2021 Share Issue/Capital Change	2021-08-03	English
VOLUNTARY ANNOUNCEMENT JACOBIO ANNOUNCES THE FIRST PATIENT DOSED IN CLINICAL TRIAL OF KRAS G12C JAB-21822 IN CHINA Regulatory Filings	2021-08-03	English
INSIDE INFORMATION PLACING OF EXISTING SHARES Capital/Financing Update	2021-07-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2021 Share Issue/Capital Change	2021-07-07	English
VOLUNTARY ANNOUNCEMENT JACOBIO ANNOUNCES FIRST TWO PATIENTS DOSED IN SHP2 COMBINATIONS STUDY Regulatory Filings	2021-06-18	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2021 Share Issue/Capital Change	2021-06-04	English
VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVES CHINA CDE INVESTIGATIONAL NEW DRUG CLEARANCE FOR KRAS G12C INHIBITOR Regulatory Filings	2021-05-28	English
ANNUAL GENERAL MEETING HELD ON MAY 25, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-25	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2021 Share Issue/Capital Change	2021-05-06	English
VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVES US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR KRAS G12C INHIBITOR Regulatory Filings	2021-05-03	English
RESIGNATION OF PRESIDENT OF RESEARCH AND DEVELOPMENT AND APPOINTMENT OF CHIEF BIOLOGIST Board/Management Information	2021-04-30	English
FORM OF PROXY FOR THE 2021 ANNUAL GENERAL MEETING AGM Information	2021-04-23	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-04-23	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-04-23	English
2020 ANNUAL REPORT Annual Report	2021-04-23	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2021 Share Issue/Capital Change	2021-04-09	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020 CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE UNDER THE LISTING RULES Annual Report	2021-03-26	English
DATE OF BOARD MEETING Report Publication Announcement	2021-03-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2021 Share Issue/Capital Change	2021-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2021 Share Issue/Capital Change	2021-02-04	English
CHANGE OF REGISTERED OFFICE AND ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS Regulatory Filings	2021-02-01	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2021-01-18	English
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2021-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2020 Share Issue/Capital Change	2021-01-07	English
VOLUNTARY ANNOUNCEMENT INVESTIGATIONAL NEW DRUG (IND) APPLICATION APPROVALS FOR SHP2 INHIBITORS IN COMBINATION THERAPIES IN CHINA AND THE UNITED STATES Regulatory Filings	2021-01-04	English